AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $234K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$234K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 2 cutEven
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 4- Open
- $64.63
- 52-wk high
- $80.53
- High
- $65.72
- 52-wk low
- $53.44
- Low
- $64.20
- Prev close
- $64.05
- Mkt cap
- $7.42B
- P/E
- 16.7x
- Volume
- 1.16M
- Fwd P/E
- 9.2x
- Beta
- 1.09
- Div yield
- 5.23%
- P/S
- 0.8x
- P/B
- 1.3x
- Profit margin
- +5.0%
- Op margin
- +12.9%
- ROE
- +7.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about EMN filings
Are insiders buying or selling Eastman Chemical Company (EMN) stock?
Net selling: insiders sold $234K and bought $0 of EMN stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. The largest was Holt, Adrian James (SVP, Chf HR Ofcr), who sold $234K. The latest filing was on Aug 6, 2026.
Which members of Congress have traded EMN recently?
None. No member of Congress disclosed a EMN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this EMN smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- MW
Marshall Wace
$65.8M
added
Sells/Trims (2)
- DS
D.E. Shaw
$28.8M
trimmed
- MI
Millennium
$24.0M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in EMN right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 9.4% above what analysts expected.
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.80 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $1.97 / $1.80Alpha Vantage | +9.44% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $1.09 / $1.06Alpha Vantage | +2.83% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 29, 2026 | $0.75 / $0.72Alpha Vantage | +4.17% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 3, 2025 | $1.14 / $1.17Alpha Vantage | -2.56% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $1.60 / $1.75Alpha Vantage | -8.57% miss | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 24, 2025 | $1.91 / $1.89Alpha Vantage | +1.06% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Jan 30, 2025 | $1.87 / $1.57Alpha Vantage | +19.11% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 31, 2024 | $2.26 / $2.14Alpha Vantage | +5.61% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 2, 2026, in 28 days
Estimates as of Oct 4, 2026
EPS expected
$1.89 to $1.99
Revenue expected
10 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.29B | $2.20B | $1.97B | $2.18B |
| Cost of what it sold | $1.78B | $1.77B | $1.64B | $1.75B |
| Gross profit | $506.0M | $433.0M | $338.0M | $431.0M |
| What it spent | ||||
| Research and development | $67.0M | $63.0M | $58.0M | $60.0M |
| Sales and admin | $155.0M | $160.0M | $159.0M | $178.0M |
| Total operating expenses | $222.0M | $223.0M | $217.0M | $238.0M |
| What was left | ||||
| Operating profit | $284.0M | $210.0M | $121.0M | $193.0M |
| Interest on debt | $56.0M | $56.0M | $52.0M | $49.0M |
| Profit before tax | $169.0M | $134.0M | $12.0M | $136.0M |
| Tax | $29.0M | $87.0M | -$93.0M | $29.0M |
| Net profit | $140.0M | $47.0M | $105.0M | $107.0M |
| EBITDA | $352.0M | $319.0M | $195.0M | $316.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace